Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.47 |
| ▸ | PLOD2 | O00469 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 6/20 | 0.41 |
| ▸ | PLOD3 | O60568 | 2/20 | 0.40 |
| ▸ | PLOD1 | Q02809 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 8/20 | 0.39 |
| ▸ | ACLY | P53396 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14973493 | 0.97 | LDHA (0.44) | LDHASRRPLOD2CES1PLOD3 | |
| SCHEMBL8645726 | 0.97 | LDHA (0.44) | LDHASRRPLOD2CES1PLOD3 | |
| SCHEMBL7544594 | 0.97 | LDHA (0.44) | LDHASRRPLOD2CES1PLOD3 | |
| Hydrochloric Acid SCHEMBL7501867 | 0.97 | LDHA (0.44) | LDHASRRPLOD2CES1PLOD3 | |
| Water SCHEMBL7191917 | 0.87 | PLOD2 (0.44) | PLOD2CES1PLOD3PLOD1FAAH | |
| Water SCHEMBL7197275 | 0.87 | PLOD2 (0.44) | PLOD2CES1PLOD3PLOD1FAAH | |
| SCHEMBL28749515 | 0.86 | LDHA (0.40) | LDHASRRPLOD2CES1PLOD3 | |
| SCHEMBL183178 | 0.83 | PLOD2 (0.46) | PLOD2CES1PLOD3PLOD1FAAH | |
| SCHEMBL6517983 | 0.80 | PLOD2 (0.44) | PLOD2CES1PLOD3PLOD1FAAH | |
| SCHEMBL9326020 | 0.80 | PLOD2 (0.44) | PLOD2CES1PLOD3PLOD1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115560-A1 | A NEW PROCESS OF SAFLUFENACIL PRODUCTION USING NOVEL INTERMEDIATES | ADAMA AGAN LTD (IL) | 2025-04-10 | — | — | US | claimed |
| EP-4025653-B1 | STAIN RESISTANT ADDITIVE | ARXADA AG (CH) | 2023-11-15 | — | — | EP | claimed |
| EP-4232028-A1 | METHODS OF MAKING NICOTINIC ACID DERIVATIVES | Vertellus Holdings LLC (US) | 2023-08-30 | — | — | EP | claimed |
| WO-2023017518-A1 | A NEW PROCESS OF SAFLUFENACIL PRODUCTION USING NOVEL INTERMEDIATES | ADAMA AGAN LTD. (IL) | 2023-02-16 | — | — | WO | claimed |
| CN-107876092-B | Application of titanium catalyst with cyclic structure as reaction catalyst for synthesizing benzyl carbonate or diphenyl carbonate by ester exchange | 华东理工大学 | 2023-01-10 | — | — | CN | claimed |
| CN-112899246-B | Aldehyde ketone reductase KmAKR mutant and application thereof in catalytic synthesis of chiral alcohol | 浙江工业大学 | 2022-06-21 | — | — | CN | claimed |
| EP-3486241-B1 | METHOD FOR PRODUCING CRYSTAL OF URACIL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2022-05-04 | — | — | EP | claimed |
| WO-2022087373-A1 | METHODS OF MAKING NICOTINIC ACID DERIVATIVES | VERTELLUS HOLDINGS LLC (US) | 2022-04-28 | — | — | WO | claimed |
| EP-2247577-B2 | METHOD FOR THE REGIOSELECTIVE SYNTHESIS OF 1-ALKYL-3-HALOALKYL-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES | BAYER IP GMBH (DE) | 2022-04-27 | — | — | EP | claimed |
| CN-114195714-A | Simple synthesis method of celecoxib | 山东铂源药业有限公司 | 2022-03-18 | — | — | CN | claimed |
| EP-0448544-B1 | Process for preparation of fluoromethyl-substituted piperidine carbodithioates | ROHM & HAAS (US) | 1996-07-03 | — | — | EP | claimed |
| EP-0546669-B1 | Preparation of fluorine-doped tungstic oxide and glass coating process | FORD MOTOR CO (GB) | 1996-04-17 | — | — | EP | claimed |
| EP-0599036-A1 | Method for the preparation of 2-aryl-5-trifluoromethyl pyrrole compounds | AMERICAN CYANAMID COMPANY (US) | 1994-06-01 | — | — | EP | claimed |
| EP-0448544-A2 | Process for preparation of fluoromethyl-substituted piperidine carbodithioates | ROHM AND HAAS COMPANY (US) | 1991-09-25 | — | — | EP | claimed |
| US-5039753-A | Polymers comprising betadiketone groups and polymerizable compositions containing said polymers | LOCTITE (IRELAND) LTD (IE) | 1991-08-13 | — | — | US | claimed |
| EP-0313387-A2 | Polymers comprising betadiketone groups and polymerizable compositions containing said polymers | LOCTITE (IRELAND) Ltd. (IE) | 1989-04-26 | — | — | EP | claimed |
| EP-0135491-B1 | HERBICIDAL 2,6-BIS-FLUOROMETHYL-DIHYDROPYRIDINE-3,5-DICARBOXYLIC ACID ESTERS | MONSANTO COMPANY (US) | 1989-01-25 | — | — | EP | claimed |
| EP-0158399-B1 | LIQUID COATING COMPOSITION FOR PRODUCING HIGH QUALITY, HIGH PERFORMANCE FLUORINE-DOPED TIN OXIDE COATINGS | M & T CHEMICALS, INC. (US) | 1988-11-02 | — | — | EP | claimed |
| EP-0206953-B1 | PROCESS FOR THE PREPARATION OF ETHYL TRIFLUOROACETOACETATE | RHONE-POULENC CHIMIE (FR) | 1988-09-07 | — | — | EP | claimed |
| EP-0206953-A1 | Process for the preparation of ethyl trifluoroacetoacetate | RHONE-POULENC CHIMIE (FR) | 1986-12-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115560-A1 | A NEW PROCESS OF SAFLUFENACIL PRODUCTION USING NOVEL INTERMEDIATES | DPYD, PDK1, CYP2S1 | LDHA 386/4885SRR 1411/4885PLOD2 3669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.